in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Merck & Co. to Acquire Schering-Plough for $41 Billion
7:16 AM MDT | March 10, 2009 | Deepti Ramesh
Merck & Co (Whitehouse Station, NJ) and Schering-Plough (Kenilworth, NJ) say their board of directors have approved a definitive merger agreement under which Merck will acquire Schering-Plough in a stock and cash transaction, for a total of about $41.1 billion. The companies expect to complete the transaction in the fourth quarter of 2009. According to the agreement, Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough and each Merck share will automatically become a share of the combined company. The...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee